News
2hon MSN
Missing messenger RNA fragments could be key to new immunotherapy for hard-to-treat brain tumors
A new study, led by researchers at Children's Hospital of Philadelphia (CHOP), identified tiny pieces of messenger RNA that ...
A new study, led by researchers at Children's Hospital of Philadelphia (CHOP), identified tiny pieces of messenger RNA that are missing in pediatric high-grade glioma tumors but not in normal brain ...
The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...
ZME Science on MSN5h
Some People Are Immune to All Viruses. Scientists Now Want To Replicate This Ability for a Universal Antiviral
Fifteen years ago, immunologist Dusan Bogunovic stumbled across a handful of patients whose bodies played by different rules.
Scientists say HHS’s decision to stop investing in mRNA vaccine research is another sign of the growing politicization of ...
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...
The rest of the world is not following the US government’s dangerous path, and will stick with the technology that helped the ...
3don MSN
Pressing pause on DNA transcription: Imaging technique reveals what happens at the atomic level
A detailed picture of what happens when DNA transcription is paused early in the process has been obtained by structural ...
A new discovery about mutations in a gene that causes ALS may allow researchers to design targeted therapies, a study found.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback